CAPGEN

What CAPGEN does

CAPGEN — formally the Cámara Argentina de Productores de Medicamentos Genéricos y de uso Hospitalario — is a non-profit trade association founded on December 13, 1999 in Buenos Aires, Argentina, that represents the country's generic and hospital-use pharmaceutical industry. The association itself is a small chamber-level entity (1-10 direct employees) whose membership comprises approximately 17 Argentine pharmaceutical laboratories that collectively operate nearly 30 industrial facilities within Argentina and employ over 3,000 operatives and professionals. CAPGEN does not manufacture, distribute, or sell pharmaceutical products directly; its role is industry representation, regulatory advocacy, and public-facing communication.

Through its member laboratories, CAPGEN facilitates a steady, ANMAT-regulated supply of generic medicines to the Argentine health system. Member laboratories are reported to supply approximately 80% of habitual-use pharmaceutical units and roughly 80% of hospital, dispensary, and institutional demand across municipal, provincial, and national levels. Distribution spans the Argentine public system (government hospitals, dispensaries, and health institutions at all levels) and the private system (private healthcare providers and pharmacies). All products are manufactured domestically under ANMAT's strict regulatory standards, and the industry economics are supported by Argentine Law 25.649 (Ley de Genéricos), which mandates INN-based generic prescribing.

CAPGEN's business model is association dues and member-funded advocacy rather than transactional revenue. Pricing of generic medicines is set by individual member laboratories and is structurally lower than brand-name equivalents given the absence of R&D amortisation; CAPGEN's own pricing is not publicly disclosed. The association markets itself through policy advocacy, a health-education blog, and engagement with international peer associations (WHO, PAHO, Medicines for Europe, Progenéricos, AAM, and the Canadian Generic Pharmaceutical Association). It is governed by an elected Board of Directors (Commission Directive) currently serving the 2026-2028 term under President Luciano Tombazzi, with day-to-day operations led by Executive Director Alejandrina Arauz.

Name

CAPGEN

Legal name

Cámara Argentina de Productores de Medicamentos Genéricos y de uso Hospitalario

Website

https://capgen.com.ar

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

CAPGEN is a Buenos Aires-based non-profit trade association, founded 1999, representing approximately 17 Argentine generic pharmaceutical laboratories that collectively operate nearly 30 facilities, employ over 3,000 people, and supply roughly 80% of Argentina's public and private hospital and habitual-use pharmaceutical demand under ANMAT regulation.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals (Trade Association Representation)

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Hospital drug supply
• Pharmaceutical trade association
• Generic drug manufacturing
• Healthcare distribution

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Pharmaceutical Product Sales (via member laboratories): Member laboratories manufacture and sell generic and hospital-use pharmaceutical products to the Argentine public and private health system, covering municipal, provincial, and national demand.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

CAPGEN is a non-profit trade association that represents Argentine pharmaceutical manufacturers of generic and hospital-use medications. Through its approximately 17 member laboratories operating nearly 30 industrial facilities in Argentina, CAPGEN coordinates a steady supply of high-quality, ANMAT-certified generic and hospital-use drugs that meet approximately 80% of the public and private Argentine health system's demand at municipal, provincial, and national levels.

Product overview

CAPGEN (Cámara Argentina de Productores de Medicamentos Genéricos y de uso Hospitalario) is an industry association representing Argentine pharmaceutical manufacturers of generic and hospital-use medications. As a chamber/association rather than a product company, CAPGEN does not develop or sell its own pharmaceutical products. Through its member laboratories, CAPGEN provides a stable supply of high-quality generic medications manufactured in Argentina under ANMAT regulatory standards. Member companies employ over 3000 people across nearly 30 industrial facilities and supply approximately 80% of hospital, healthcare center, and institutional drug demand at municipal, provincial, and national levels. The association promotes access to affordable quality medicines and advocates for the generic pharmaceutical industry in Argentina.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Approximately 80% of habitual-use units supplied to the Argentine public and private health system at all government levels
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Ministerio de Salud de la Nación (Argentina)coreOthersArgentina's National Ministry of Health is the government body that sets health policies and regulations. CAPGEN collaborates with the Ministry as the representative of the Argentine generic pharmaceutical industry, working to ensure access to affordable generic medicines within the national health system.
• ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)coreOthersANMAT is Argentina's national regulatory authority for drugs, food, and medical devices. All CAPGEN member laboratories manufacture under ANMAT's strict regulatory standards. ANMAT approves and certifies the quality, safety, and efficacy of all pharmaceutical products produced by member companies.
• World Health Organization (WHO)minorStrategic or Co-development PartnerCAPGEN references WHO as a linked international health organization on its Enlaces (Links) page, indicating alignment with global health standards and policies promoted by WHO for essential medicines and generic drug accessibility.
• Pan American Health Organization (PAHO)minorStrategic or Co-development PartnerPAHO is listed as an international organization link on CAPGEN's Enlaces page, reflecting shared goals in promoting access to essential medicines and public health across the Americas.
• Medicines for EuropeminorStrategic or Co-development PartnerEuropean association of generic medicine producers referenced by CAPGEN on its Enlaces page. Represents a regional peer association with shared goals of promoting generic medicines, affordability, and patient access across Europe.
• Progenéricos (Brazilian Association of Generic Drug Industries)minorStrategic or Co-development PartnerBrazilian association of generic drug manufacturers listed as an international association link by CAPGEN, indicating regional collaboration and shared industry representation in South America.
• AAM – Association for Accessible Medicines (USA)minorStrategic or Co-development PartnerUS association for accessible medicines listed on CAPGEN's Enlaces page, reflecting shared advocacy for generic drug accessibility and affordability.
• Canadian Generic Pharmaceutical AssociationminorStrategic or Co-development PartnerCanadian generic pharmaceutical association listed as an international peer organization on CAPGEN's Enlaces page, indicating cross-country industry alignment.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Medicines for Europe: European trade association representing generic and biosimilar medicine manufacturers. Directly comparable to CAPGEN as a regional generic-pharma industry chamber; CAPGEN explicitly lists it as an international peer.
• International Generic and Biosimilar Medicines Association (IGBA): Global umbrella body for national generic-medicine associations. CAPGEN's individual member labs and the chamber itself operate within IGBA's network, making it a natural global-level peer.
• Association for Accessible Medicines (AAM): US trade association representing generic and biosimilar manufacturers. Operates the same industry-representation model as CAPGEN and is listed by CAPGEN as an international peer.
• Progenéricos (Associação Brasileira das Indústrias de Medicamentos Genéricos): Brazilian generic pharmaceutical industry association. Closest geographic peer to CAPGEN — same model, same product category, and a regional counterpart CAPGEN cites directly.
• Canadian Generic Pharmaceutical Association: National association representing Canada's generic pharmaceutical industry. Same trade-association model as CAPGEN, with similar regulatory and policy-advocacy functions; cited by CAPGEN as a peer.

Regional players

• Japan Generic Medicines Association (JGA): Japanese association for generic medicine manufacturers. Operates the same industry-representation model as CAPGEN but serves Japan; useful as a regional comparator on generic uptake and policy advocacy.
• Korean Pharmaceutical Manufacturers Association (KPMA): Korean pharmaceutical industry association including generic manufacturers. Same trade-body function as CAPGEN but Korea-focused; relevant as an Asian comparator on generic industry representation.
• Indian Pharmaceutical Alliance (IPA): Industry body representing leading Indian generic manufacturers. Comparable industry-association role, but India-focused and not directly competitive with CAPGEN's Argentine remit; relevant as a global generics representative body.
• Cámara Industrial de Laboratorios Farmacéuticos Argentinos (CILFA): Argentine pharma industry chamber primarily representing brand-name (innovator) laboratories. Same Argentine regulatory and policy ecosystem as CAPGEN, but representing the complementary branded-pharma side rather than generic manufacturers.
• Generic and Biosimilar Medicines Association (GBMA, Australia): Australian association for generic and biosimilar medicine suppliers. Equivalent role to CAPGEN in Australia; comparable advocacy and policy functions but serving a different geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/capgen.medicamentos.accesibles

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAPGEN